| abstract |
The present invention provides humanized antibodies, including masked antibodies that specifically bind to CD47. Provide methods of using anti-CD47 antibodies (including masked antibodies) to modulate the activity of CD47 expressing cells (e.g., inhibit the proliferation of CD47 expressing cells) and to treat one or more diseases or disorders associated with CD47 expressing cells (e.g. Cancer) method. |